http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 전나경 (검색결과 7 건)
- 무료
- 기관 내 무료
- 유료
-
-
-
-
순회교사제의 문제점 진단 및 해결방안 탐색 연구 : 충남지역 소재 학교에 근무 중인 전·현직 순회교사 대상으로
이서정, 전나경, 조희주, 최유나, 최효주 국립공주대학교 교직부 2021 공주대학교 예비교사 교육연구 Vol.1 No.
본 연구는 현재 순회교사제의 운영 실태와 교육현장에서 순회교사가 겪는 어려움을 탐색하고 이를 제도적 기반을 바탕으로 분석함으로써 순회교사제의 개선 방향을 제시하는 것에 목적이 있다. 이를 위해 충청남도 소재 중등학교에 근무 중인 전·현직 순회교사 5명과 순회교사 관련 업무를 담당한 경험이 있는 전 장학사 1명을 대상으로 면담을 진행하였다. 연구 결과, 교사는 순회교사 선정 및 배정을 일방적인 통보라고 느꼈으며 학생과의 래포 형성 및 상호작용에 어려움을 겪는 것으로 나타났다. 또한 순회교 교사와의 관계에서 심리적인 거리감과 불편함을 경험하였으며, 다른 학교로 순회를 나가기 때문에 수업 준비, 교구 활용, 시험 출제 및 채점 등 교육과정 운영에 있어서도 어려움을 느꼈다. 따라서 교사들은 순회교사제가 교육적 측면에서 부정적인 영향을 끼치며, 순회교사를 줄이고 교과교사를 학교마다 배치할 필요가 있다고 하였다. 이를 바탕으로 연구진은 교사 의견을 반영한 순회교사 선정, 공식 일정에 맞춘 학교의 순회계획 전달, 순회교의 포용적 분위기 조성, 양질의 교육 제공을 위한 순회교사 개인 및 제도적 방안 마련, 충분한 순회지도 준비기간 확보를 순회교사제의 개선을 위한 방안으로 제안하였다.
-
코로나19의 사회경제적 부담과 영향에 대한 체계적 문헌고찰:팬데믹 초기의 의료자원 활용과 산업적 시사점을 중심으로
정세원,육성수,전나경,윤금비,한종성,이한길 한국보건사회약료경영학회 2024 한국보건사회약료경영학회지 Vol.12 No.1
BACKGROUNDS COVID-19 pandemic has caused great losses to the national macroeconomy beyond the shortage of health care resources. OBJECTIVES This study systematically reviewed previous literature to evaluate the socioeconomic impact of the COVID-19 pandemic on South Korea. METHODS Searches were performed on PubMed and manually in Google Scholar, spanning from January 2020 to August 2023. Two reviewers independently chose studies based on pre-defined inclusion/exclusion criteria and followed the PRISMA guideline. Covidence, a semi-automated program, was used to facilitate the review process. RESULTS After reviewing 367 studies in a two-step process, we finally selected 10 relevant papers. These papers covered various topics: four focused on direct medical costs and healthcare resource utilization, four on the labor market, and two on macro economy and industry. Treatment costs (KRW 2.97 trillion, 41.8%) accounted for the largest portion of national health insurance-covered expenditures from January 2020 to June 2022, followed by KRW 2.34 trillion for diagnostic tests, KRW 1.10 trillion for vaccines and other expenses. In the early stage of COVID-19, the national employment rate dropped by 0.89%, with a particularly steep decline observed in small-sized businesses. Short-term job losses in the service industry and long-term downsizing in the manufacturing sector were noted. The pandemic disproportionately affected irregular, young workers, and the self-employed. CONCLUSION This study reveals that COVID-19 significantly impacted not only on direct medical costs but also on the labor market and the broader economy. Discussions are essential to mitigate socioeconomic losses.
-
파킨슨 병 이외의 적응증을 가진 환자의 Pramipexole 혹은 Ropinirole 사용과 관련된 충동 조절 장애 : 주제 범위 문헌 고찰
정태현,서승민,송현진,전나경 한국임상약학회 2020 한국임상약학회지 Vol.30 No.4
Background: Dopamine receptor agonists (DRAs) have been associated with impulse control disorders (ICDs) in Parkinson’s disease (PD) in preliminary studies. Whether the association holds true when DRAs are used to treat non-PD, such as restless legs syndrome, prolactinoma, and several mood disorders is uncertain. Objective: The present study aimed to understand the research gaps related to the risk of ICDs associated with pramipexole or ropinirole (PRX/ROP) use as a treatment for specific underlying diseases, excluding Parkinson’s disorders. Methods: We conducted a scoping review, systematically searching databases to identify literature on the types, prevalence, and factors associated with ICD in non-PD patients receiving PRX/ROP. All relevant information that helped understand the epidemiology of ICDs among non-PD patients taking PRX/ROP were extracted and analyzed. We also evaluated the potential associations between PRX/ROP and ICDs, utilizing the Naranjo scale or statistical analysis, depending on the type of literature. Results: We included 24 articles (19 case reports or case series and 5 populationbased studies) in this scoping review. Evaluating the 19 case reports or case series using Naranjo scores led to the discovery of a possible link between PRX/ROP exposure and ICDs. However, important information to assess causality is frequently missing. Moreover, the population-based studies lack diversity in the study populations and enough study samples to draw conclusive results. Conclusion: Our scoping review suggests that the currently available literature requires more details in future case reports and for well-powered studies in various disease conditions where PRX/ROP is frequently used.
-
국내 인슐린 주입기기 요양비 지원 정책 현황 및 개선 방안
윤이정(E Zeong Yoon),김재현(Jae Hyeon Kim),전나경(Nakyung Jeon) 대한약학회 2022 약학회지 Vol.66 No.4
Intensive insulin therapy is the primary treatment option for patients with type 1 and uncontrolled type 2 diabetes. Insulin pump therapy and multiple daily insulin injections (MDI) are the principal methods of intensive insulin therapy. The clinical utility of an insulin pump is generally greater than an MDI regimen. An artificial pancreas, which is an insulin pump with an integrated continuous glucose monitor (CGM), has recently been introduced on the market with emerging clinical evidence. Although it may offer clinical benefits and reduce the self-management burden among patients with diabetes, its potential for inappropriate use and unaffordability are the major barriers to its universal utilization. Despite the medical assistance program offered by the Korean National Healthcare System, which provides coverage for consumables and devices for diabetes treatment, some patients cannot afford to use an advanced insulin delivery system (i.e., the artificial pancreas). Under the current reimbursement policy, the healthcare system considers an insulin pump and a CGM as separate items for regulatory and reimbursement purposes. In other words, the artificial pancreas is categorized as an insulin pump and reimbursed at the same amount as a traditional insulin pump. The fundamental operating function may be the same between the artificial pancreas and a traditional insulin pump; however, there should be a different reimbursement pathway to make a novel category for the artificial pancreas instead of categorizing it under insulin pumps and to differentiate pricing based on the comparative (cost-) effectiveness among insulin delivery devices. Other countries such as the United States, the United Kingdom, Germany, and France are moving toward rapid and universal adoption of the artificial pancreas supported by their clinical governance and regulatory affairs. In this review, we highlight the need to improve the accessibility and affordability of advanced diabetes technology by discussing the current issues in the reimbursement policy that limit the universal use of advanced insulin delivery devices in Korea.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
